May 15, 2024Open Access

Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis

Key Points

Key points are not available for this paper at this time.

Abstract

Both atrial fibrillation (AF) and amyloidosis increase stroke risk. We evaluated the best anticoagulation strategy in AF patients with coexistent amyloidosis.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Mohanty et al. (Wed,) studied this question.

synapsesocial.com/papers/68e69d64b6db64358762311d https://doi.org/https://doi.org/10.1111/jce.16308

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation2020 · 614 citations
2Bleeding Risk of Direct Oral Anticoagulants in Patients With Heart Failure And Atrial Fibrillation2021 · 46 citations
3Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding2020 · 65 citations
4The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre2022 · 14 citations
5Intracardiac echocardiography‐ versus transesophageal echocardiography‐guided left atrial appendage occlusion with Watchman FLX2021 · 29 citations

Bookmark

View Full Paper